CP
Corbus Pharmaceuticals Holding
🇺🇸XNAS.CRBPUnited StatesHealthcare
$7.21USDup +0.28 (+4.04%)OpenDelayed6:07 PM
Price$7.21+0.28 (+4.04%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US21833P3010
- CUSIP
- 21833P103
Company
- Employees
- 36
- Headquarters
- Norwood, United States
- Website
- https://www.corbuspharma.com
- CEO
- Dr. Yuval Cohen Ph.D.
Market
- Shares outstanding
- 19.3M
- Market cap
- $139.45M
Highlights
- Market cap
- $134.04M
- EPS LTM
- -$5.27calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.37calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$101.9M-75.84%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$86.69M-49.71%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.